Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity (original) (raw)

• Porcelli, S. A. & Modlin, R. L. The CD1 system: antigen-presenting molecules for T-cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17, 297–329 (1999).
  Article CAS PubMed Google Scholar
• Brossay, L. & Kronenberg, M. Highly conserved antigen-presenting function of CD1d molecules. Immunogenetics 50, 146–151 (1999).
  CAS PubMed Google Scholar
• Koseki, H., Imai, K., Ichikawa, T., Hayata, I. & Taniguchi, M. Predominant use of a particular α-chain in suppressor T-cell hybridomas specific for keyhole limpet hemocyanin. Int. Immunol. 1, 557–564 (1989).
  CAS PubMed Google Scholar
• Balk, S. P. et al. Oligoclonal expansion and CD1 recognition by human intestinal intraepithelial lymphocytes. Science 253, 1411–1415 (1991).
  CAS PubMed Google Scholar
• Porcelli, S., Yockey, C. E., Brenner, M. B. & Balk, S. P. Analysis of T-cell antigen receptor (TCR) expression by human peripheral blood CD4−8− αβ T cells demonstrates preferential use of several Vβ genes and an invariant TCR α-chain. J. Exp. Med. 178, 1–16 (1993).
  CAS PubMed Google Scholar
• Singh, N. et al. Cutting edge: activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a TH2 phenotype. J. Immunol. 163, 2373–2377 (1999).
  CAS PubMed Google Scholar
• Bendelac, A. et al. CD1 recognition by mouse NK1.1+ T lymphocytes. Science 268, 863–865 (1995). In this study, the mouse CD1d protein was identified as the restricting element for invariant natural killer T (iNKT) cells.
  CAS PubMed Google Scholar
• Godfrey, D. I. et al. NKT cells: facts, functions and fallacies. Immunol. Today 21, 573–583 (2000).
  CAS PubMed Google Scholar
• Kronenberg, M. & Gapin, L. The unconventional lifestyle of NKT cells. Nature Rev. Immunol. 2, 557–568 (2002).
  Article CAS Google Scholar
• Kawano, T. et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278, 1626–1629 (1997). This paper describes how synthetic α-galactosyl ceramides (α-GalCer) were discovered as the first known antigens for iNKT cells.
  CAS PubMed Google Scholar
• Gumperz, J. E., Miyake, S., Yamamura, T. & Brenner, M. B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195, 625–636 (2002). Together with reference 12, this study showed that when examined ex vivo , CD4+ iNKT cells preferentially secrete T H 2-like cytokines compared with double-negative (DN) iNKT cells.
  CAS PubMed PubMed Central Google Scholar
• Lee, P. T., Benlagha, K., Teyton, L. & Bendelac, A. Distinct functional lineages of human Vα24 natural killer T cells. J. Exp. Med. 195, 637–641 (2002).
  CAS PubMed PubMed Central Google Scholar
• Delovitch, T. L. & Singh, B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7, 727–738 (1997).
  Article CAS PubMed Google Scholar
• Bach, J. F. & Chatenoud, L. Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19, 131–161 (2001).
  CAS PubMed Google Scholar
• Bendelac, A., Rivera, M. N., Park, H. -S. & Roark, J. H. Mouse CD1-specific NK1 T cells: development, specificity and function. Annu. Rev. Immunol. 15, 535–562 (1997).
  CAS PubMed Google Scholar
• Bendelac, A., Hunziker, R. D. & Lantz, O. Increased interleukin-4 and immunoglobulin-E production in transgenic mice overexpressing NK1 T cells. J. Exp. Med. 184, 1285–1293 (1996).
  CAS PubMed Google Scholar
• Wilson, S. B. et al. Multiple differences in gene expression in regulatory Vα24JαQ T cells from identical twins discordant for type I diabetes. Proc. Natl Acad. Sci. USA 97, 7411–7416 (2000).
  CAS PubMed PubMed Central Google Scholar
• Yang, O. O. et al. CD1d on myeloid dendritic cells stimulates cytokine secretion and cytolytic activity of Vα24JαQ T cells: a feedback mechanism for immune regulation. J. Immunol. 165, 3756–3762 (2000).
  CAS PubMed Google Scholar
• Wilson, S. B. & Byrne, M. C. Gene expression in NKT cells: defining a functionally distinct CD1d-restricted T-cell subset. Curr. Opin. Immunol. 13, 555–561 (2001).
  CAS PubMed Google Scholar
• Smiley, S. T., Kaplan, M. H. & Grusby, M. J. Immunoglobulin-E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275, 977–979 (1997). This study showed that T H 2-cell responses can be generated in the absence of CD1d.
  CAS PubMed Google Scholar
• Noben-Trauth, N. et al. An interleukin-4 (IL-4)-independent pathway for CD4+ T-cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc. Natl Acad. Sci. USA 94, 10838–10843 (1997).
  CAS PubMed PubMed Central Google Scholar
• Eberl, G. et al. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 162, 6410–6419 (1999).
  CAS PubMed Google Scholar
• Matsuda, J. L. et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192, 741–754 (2000). This study was the first to show iNKT-cell responses ex vivo using CD1d tetramers loaded with α-GalCer.
  CAS PubMed PubMed Central Google Scholar
• Matsuda, J. L. et al. Homeostasis of Vα14i NKT cells. Nature Immunol. 3, 966–974 (2002).
  CAS Google Scholar
• Sharif, S. et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nature Med. 7, 1057–1062 (2001). Together with references 26, 40 and 41, this study showed the protective effect of α-GalCer in non-obese diabetic (NOD) mice.
  CAS PubMed Google Scholar
• Naumov, Y. N. et al. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic-cell subsets. Proc. Natl Acad. Sci. USA 98, 13838–13843 (2001). This study showed that the protective effect of α-GalCer therapy in NOD mice was, in part, due to the recruitment of tolerogenic dendritic cells (DCs) to the pancreatic lymph nodes.
  CAS PubMed PubMed Central Google Scholar
• Nieuwenhuis, E. E. et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nature Med. 8, 588–593 (2002). This study showed the importance of iNKT cells and monocytes for the acute control of infections in the lung.
  CAS PubMed Google Scholar
• Apostolou, I. et al. Murine natural killer T (NKT) cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc. Natl Acad. Sci. USA 96, 5141–5146 (1999).
  CAS PubMed PubMed Central Google Scholar
• Kita, H. et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 123, 1031–1043 (2002).
  CAS PubMed Google Scholar
• Kim, C. H., Johnston, B. & Butcher, E. C. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among Vα24+Vβ11+ NKT-cell subsets with distinct cytokine-producing capacity. Blood 100, 11–16 (2002). This study identified preferential chemokine-receptor expression by human CD4+ and DN iNKT cells.
  CAS PubMed Google Scholar
• Faunce, D. E., Sonoda, K. H. & Stein-Streilein, J. MIP-2 recruits NKT cells to the spleen during tolerance induction. J. Immunol. 166, 313–321 (2001).
  CAS PubMed Google Scholar
• Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S. & Delovitch, T. L. Regulation of autoimmune disease by natural killer T cells. J. Mol. Med. 80, 290–300 (2002).
  CAS PubMed Google Scholar
• Cameron, M. J. et al. Differential expression of CC-chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J. Immunol. 165, 1102–1110 (2000).
  CAS PubMed Google Scholar
• Gombert, J. M. et al. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur. J. Immunol. 26, 2989–2998 (1996). This report was the first demonstration of decreased frequency and loss of function of iNKT cells in NOD mice.
  CAS PubMed Google Scholar
• Falcone, M. et al. A defect in interleukin-12-induced activation and interferon-γ secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J. Exp. Med. 190, 963–972 (1999).
  CAS PubMed PubMed Central Google Scholar
• Wilson, S. B. et al. Extreme TH1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 391, 177–181 (1998). This report was the first demonstration of decreased frequency and loss of function of iNKT cells in humans with insulin-dependent diabetes mellitus.
  CAS PubMed Google Scholar
• Mieza, M. A. et al. Selective reduction of Vα14+ NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156, 4035–4040 (1996).
  CAS PubMed Google Scholar
• Kukreja, A. et al. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109, 131–140 (2002).
  CAS PubMed PubMed Central Google Scholar
• Baxter, A. G. et al. Association between αβTCR+CD4−CD8− T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46, 572–582 (1997).
  CAS PubMed Google Scholar
• Wang, B., Geng, Y. B. & Wang, C. R. Cd1-restricted NKT cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 194, 313–320 (2001). Together with references 26 and 50, this study showed an exacerbation of autoimmune diabetes in CD1d-deficient NOD mice.
  PubMed PubMed Central Google Scholar
• Hong, S. et al. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nature Med. 7, 1052–1056 (2001).
  CAS PubMed Google Scholar
• Mempel, M. et al. Comparison of the T-cell patterns in leprous and cutaneous sarcoid granulomas. Presence of Vα24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T-cell receptor Vα repertoire. Am. J. Pathol. 157, 509–523 (2000).
  CAS PubMed PubMed Central Google Scholar
• Grattan, M., Mi, Q. S., Meagher, C. & Delovitch, T. L. Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci. Diabetes 51, 215–223 (2002).
  CAS PubMed Google Scholar
• Lee, P. T. et al. Testing the NKT-cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 110, 793–800 (2002).
  CAS PubMed PubMed Central Google Scholar
• Oikawa, Y. et al. High frequency of Vα24+Vβ11+ T cells observed in type 1 diabetes. Diabetes Care 25, 1818–1823 (2002).
  PubMed Google Scholar
• Chatenoud, L. Do NKT cells control autoimmunity? J. Clin. Invest. 110, 747–748 (2002).
  CAS PubMed PubMed Central Google Scholar
• Hammond, K. I. L. et al. αβ T-cell receptor (TCR)+CD4−CD8− (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187, 1047–1056 (1998). This study showed the importance of iNKT cells, IL-4 and IL-10 for protecting NOD mice from autoimmune diabetes by transfer of iNKT cells into naive pre-diabetic NOD mice.
  CAS PubMed PubMed Central Google Scholar
• Lehuen, A. et al. Overexpression of natural killer T cells protects Vα14–Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188, 1831–1839 (1998).
  CAS PubMed PubMed Central Google Scholar
• Gombert, J. M. et al. IL-7 reverses NK1+ T-cell-defective IL-4 production in the non-obese diabetic mouse. Int. Immunol. 8, 1751–1758 (1996).
  CAS PubMed Google Scholar
• Shi, F. D. et al. Germ-line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc. Natl Acad. Sci. USA 98, 6777–6782 (2001).
  CAS PubMed PubMed Central Google Scholar
• Beaudoin, L. et al. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic β-cells. Immunity 17, 725–736 (2002). This study showed an important contribution of iNKT cells to the inhibition of pathogenic islet-specific T cells.
  CAS PubMed Google Scholar
• Sumida, T. et al. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J. Exp. Med. 182, 1163–1168 (1995). This early study was the first to show a paucity of iNKT cells in a human autoimmune disorder.
  CAS PubMed Google Scholar
• Yoshimoto, T., Bendelac, A., Hu-Li, J. & Paul, W. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin-4. Proc. Natl Acad. Sci. USA 92, 11931–11934 (1995).
  CAS PubMed PubMed Central Google Scholar
• Illes, Z. et al. Differential expression of NKT cell Vα24JαQ invariant TCR chains in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J. Immunol. 164, 4375–4381 (2000).
  CAS PubMed Google Scholar
• van der Vliet, H. J. et al. Circulating Vα24+Vβ11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100, 144–148 (2001).
  CAS PubMed Google Scholar
• Zeng, D., Lee, M. K., Tung, J., Brendolan, A. & Strober, S. Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J. Immunol. 164, 5000–5004 (2000).
  CAS PubMed Google Scholar
• Nagane, Y., Utsugisawa, K., Obara, D. & Tohgi, H. NKT-associated markers and perforin in hyperplastic thymuses from patients with myasthenia gravis. Muscle Nerve 24, 1359–1364 (2001).
  CAS PubMed Google Scholar
• Saubermann, L. J. et al. Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 119, 119–128 (2000).
  CAS PubMed Google Scholar
• Singh, A. K. et al. Natural killer T-cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194, 1801–1811 (2001).
  CAS PubMed PubMed Central Google Scholar
• Jahng, A. W. et al. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194, 1789–1799 (2001). This study showed the Janus nature of iNKT cells in experimental allergic encephalomyelitis (EAE).
  CAS PubMed PubMed Central Google Scholar
• Pal, E. et al. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NK T cells. J. Immunol. 166, 662–668 (2001).
  CAS PubMed Google Scholar
• Miyamoto, K., Miyake, S. & Yamamura, T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413, 531–534 (2001). This study identified the dependence of protection from EAE on IL-4, potent effects of structural analogues on the T H -cell phenotype of iNKT cells and the adaptive immune response.
  CAS PubMed Google Scholar
• Hayakawa, Y. et al. Differential regulation of TH1 and TH2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166, 6012–6018 (2001).
  CAS PubMed Google Scholar
• Cui, J. et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623–1626 (1997).
  CAS PubMed Google Scholar
• Smyth, M. J. et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191, 661–668 (2000). This study showed the importance of iNKT cells for the surveillance of subsets of endogenously occurring tumours.
  CAS PubMed PubMed Central Google Scholar
• Kitamura, H. et al. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189, 1121–1128 (1999).
  CAS PubMed PubMed Central Google Scholar
• Tomura, M. et al. A novel function of Vα14+CD4+ NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 163, 93–101 (1999).
  CAS PubMed Google Scholar
• Smyth, M. J. et al. Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 99, 1259–1266 (2002). This study dissected the temporal requirements for IFN-γ, iNKT cells, DCs and NK cells for tumour surveillance.
  CAS PubMed Google Scholar
• Crowe, N. Y., Smyth, M. J. & Godfrey, D. I. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J. Exp. Med. 196, 119–127 (2002).
  CAS PubMed PubMed Central Google Scholar
• Carnaud, C. et al. Cutting edge. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163, 4647–4650 (1999).
  CAS PubMed Google Scholar
• Fernandez, N. C. et al. Dendritic cells directly trigger NK-cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nature Med. 5, 405–411 (1999).
  CAS PubMed Google Scholar
• Terabe, M. et al. NKT-cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway. Nature Immunol. 1, 515–520 (2000). This study showed the inhibitory role that iNKT cells can sometimes have during tumour surveillance.
  CAS Google Scholar
• Tahir, S. M. et al. Loss of IFN-γ production by invariant NK T cells in advanced cancer. J. Immunol. 167, 4046–4050 (2001). This study showed the loss of, and the development of, a T H 2-cell-like phenotype by iNKT cells in patients with prostate cancer.
  CAS PubMed Google Scholar
• Ludewig, B. et al. Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J. Exp. Med. 191, 795–804 (2000).
  CAS PubMed PubMed Central Google Scholar
• Pittet, M. J. et al. High frequencies of naive Melan-A/MART-1-specific CD8+ T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J. Exp. Med. 190, 705–715 (1999).
  CAS PubMed PubMed Central Google Scholar
• Mach, N. et al. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte–macrophage colony-stimulating factor or Flt3-ligand. Cancer Res. 60, 3239–3246 (2000).
  CAS PubMed Google Scholar
• Mathis, D., Vence, L. & Benoist, C. β-cell death during progression to diabetes. Nature 414, 792–798 (2001).
  CAS PubMed Google Scholar
• Hoglund, P. et al. Initiation of autoimmune diabetes by developmentally regulated presentation of islet-cell antigens in the pancreatic lymph nodes. J. Exp. Med. 189, 331–339 (1999). This study showed the importance of regional lymph-node antigen presentation for the development of autoimmune diabetes in mice.
  CAS PubMed PubMed Central Google Scholar
• Green, E. A. & Flavell, R. A. The temporal importance of TNF-α expression in the development of diabetes. Immunity 12, 459–469 (2000). This study showed the importance of inflammatory cytokine secretion and rate of cell death in promoting autoimmune diabetes in mice.
  CAS PubMed Google Scholar
• Sauter, B. et al. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191, 423–434 (2000). This study showed that the development of DC effector function depends on the nature of the cell that a DC encounters.
  CAS PubMed PubMed Central Google Scholar
• Steinman, R. M., Turley, S., Mellman, I. & Inaba, K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191, 411–416 (2000).
  CAS PubMed PubMed Central Google Scholar
• Hawiger, D. et al. Dendritic cells induce peripheral T-cell unresponsiveness under steady-state conditions in vivo. J. Exp. Med. 194, 769–779 (2001).
  CAS PubMed PubMed Central Google Scholar
• Steinman, R. M. & Nussenzweig, M. C. Inaugural article. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T-cell tolerance. Proc. Natl Acad. Sci. USA 99, 351–358 (2002).
  CAS PubMed PubMed Central Google Scholar
• Clare-Salzler, M. J., Brooks, J., Chai, A., Van Herle, K. & Anderson, C. Prevention of diabetes in nonobese diabetic mice by dendritic-cell transfer. J. Clin. Invest. 90, 741–748 (1992). This was the first study to show the protective effect of myeloid DCs derived from the pancreatic lymph nodes in NOD mice.
  CAS PubMed PubMed Central Google Scholar
• Johnson, E. A., Silveira, P., Chapman, H. D., Leiter, E. H. & Serreze, D. V. Inhibition of autoimmune diabetes in nonobese diabetic mice by transgenic restoration of H2-E MHC class II expression: additive, but unequal, involvement of multiple APC subtypes. J. Immunol. 167, 2404–2410 (2001).
  CAS PubMed Google Scholar
• Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C. & Bhardwaj, N. Antigen-specific inhibition of effector T-cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193, 233–238 (2001).
  CAS PubMed PubMed Central Google Scholar
• Albert, M. L., Jegathesan, M. & Darnell, R. B. Dendritic-cell maturation is required for the cross-tolerization of CD8+ T cells. Nature Immunol. 2, 1010–1017 (2001).
  CAS Google Scholar
• Menges, M. et al. Repetitive injections of dendritic cells matured with tumor-necrosis factor-α induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195, 15–21 (2002). This study showed the tolerogenic function of DCs.
  CAS PubMed PubMed Central Google Scholar
• Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767–811 (2000).
  CAS PubMed Google Scholar
• Pulendran, B., Palucka, K. & Banchereau, J. Sensing pathogens and tuning immune responses. Science 293, 253–256 (2001).
  CAS PubMed Google Scholar
• Rissoan, M. C. et al. Reciprocal control of T helper cell and dendritic-cell differentiation. Science 283, 1183–1186 (1999). This study showed T H 1- and T H 2-promoting effector functions for human myeloid and lymphoid DCs, respectively.
  CAS PubMed Google Scholar
• Liu, Y. J., Kanzler, H., Soumelis, V. & Gilliet, M. Dendritic-cell lineage, plasticity and cross-regulation. Nature Immunol. 2, 585–589 (2001).
  CAS Google Scholar
• Shreedhar, V. et al. Dendritic cells require T cells for functional maturation in vivo. Immunity 11, 625–636 (1999). This study showed the importance of continued T-cell–DC cross-talk for DC survival.
  CAS PubMed Google Scholar
• Vincent, M. S. et al. CD1-dependent dendritic-cell instruction. Nature Immunol. 3, 1163–1168 (2002).
  CAS Google Scholar
• Kadowaki, N. et al. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J. Exp. Med. 193, 1221–1226 (2001).
  CAS PubMed PubMed Central Google Scholar
• Ikarashi, Y. et al. Dendritic-cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon-γ production. J. Exp. Med. 194, 1179–1186 (2001).
  CAS PubMed PubMed Central Google Scholar
• Leslie, D. S. et al. CD1-mediated γδ T-cell maturation of dendritic cells. J. Exp. Med. 196, 1575–1584 (2002).
  CAS PubMed PubMed Central Google Scholar
• Mi, Q. -S., Meagher, C. & Delovitch, T. L. in Novartis Foundation Symposium 252. Generation and Effector Functions of Regulatory Lymphocytes (Wiley, Europe) (in the press).
• Cruikshank, W. W., Kornfeld, H. & Center, D. M. Interleukin-16. J. Leukocyte Biol. 67, 757–766 (2000).
  CAS PubMed Google Scholar
• Mars, L. T. et al. Vα14–Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J. Immunol. 168, 6007–6011 (2002).
  CAS PubMed Google Scholar
• Sonoda, K. H. et al. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190, 1215–1226 (1999). This study showed the importance of iNKT cells and myeloid antigen-presenting cells expressing CD1d for the generation of antigen-specific tolerance.
  CAS PubMed PubMed Central Google Scholar
• Sonoda, K. H. et al. NK T-cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 166, 42–50 (2001).
  CAS PubMed Google Scholar
• Takahashi, K., Honeyman, M. C. & Harrison, L. C. Impaired yield, phenotype and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes. J. Immunol. 161, 2629–2635 (1998).
  CAS PubMed Google Scholar
• Serreze, D. V., Gaskins, H. R. & Leiter, E. H. Defects in the differentiation and function of antigen-presenting cells in NOD/Lt mice. J. Immunol. 150, 2534–2543 (1993).
  CAS PubMed Google Scholar
• King, C. et al. Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses. Nature Med. 7, 206–214 (2001).
  CAS PubMed Google Scholar
• O'Hara, R. M. Jr, Henderson, S. L. & Nagelin, A. Prevention of a TH1 disease by a TH1 cytokine: IL-12 and diabetes in NOD mice. Ann. NY Acad. Sci. 795, 241–249 (1996).
  CAS PubMed Google Scholar
• Alleva, D. G. et al. Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-α and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes 49, 1106–1115 (2000).
  CAS PubMed Google Scholar
• Poligone, B. et al. Elevated NF-κB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. J. Immunol. 168, 188–196 (2002).
  CAS PubMed Google Scholar
• Osman, Y. et al. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur. J. Immunol. 30, 1919–1928 (2000).
  CAS PubMed Google Scholar
• Giaccone, G. et al. A Phase I study of the NKT-cell ligand α-galactosylceramide (KRN7000) in patients with solid tumors. Clin. Cancer Res. 8, 3702–3709 (2002).
  CAS PubMed Google Scholar
• Okai, M. et al. Human peripheral blood Vα24+Vβ11+ NKT cells expand following administration of α-galactosylceramide-pulsed dendritic cells. Vox. Sang. 83, 250–253 (2002).
  CAS PubMed Google Scholar
• Heller, F. et al. Oxazolone colitis, a TH2 colitis model resembling ulcerative colitis is mediated by IL-13-producing NK-T cells. Immunity 17, 629–638 (2002).
  CAS PubMed Google Scholar
• Fujii, S. -I., Shimizu, K., Kronenberg, M. & Steinman, R. M. Prolonged interferon-γ-producing NKT response induced with α-galactosylceramide-loaded DCs. Nature Immunol. 3, 867–874 (2002).
  CAS Google Scholar